Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Preferred Stock Liabilities (2020 - 2021)

GeneDx Holdings has reported Preferred Stock Liabilities over the past 2 years, most recently at $334.4 million for Q2 2021.

  • Quarterly results put Preferred Stock Liabilities at $334.4 million for Q2 2021, up 54.04% from a year ago — trailing twelve months through Jun 2021 was $334.4 million (up 54.04% YoY), and the annual figure for FY2020 was $334.4 million, up 54.04%.
  • Preferred Stock Liabilities for Q2 2021 was $334.4 million at GeneDx Holdings, roughly flat from $334.4 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for WGSWW hit a ceiling of $334.4 million in Q3 2020 and a floor of $217.1 million in Q2 2020.